197
Participants
Start Date
April 30, 2008
Primary Completion Date
June 30, 2009
Study Completion Date
August 31, 2009
EHT 0202 etazolate
In each arm, 2 capsules of study treatment (capsules of EHT0202 40mg and/or placebo) are taken twice a day during breakfast and dinner over a 3-month treatment period. There is non treatment adjustment.
Placebo
In each arm, 2 capsules of study treatment (capsules of EHT0202 40mg and/or placebo) are taken twice a day during breakfast and dinner over a 3-month treatment period. There is non treatment adjustment.
Cabinet Médical, Rodez
Cabinet Médical, Dijon
Cabinet Médical, Saint-Brieuc
Cabinet Médical, Bergerac
Purpan-Casselardit Hospital - University of Toulouse, Toulouse
Cabinet Médical, Montpellier
Cabinet Médical 2, Montpellier
CHU Rennes, Rennes
CHU Nantes Hôpital Laennec, Nantes
Roger Salengro Hospital, Lille
CHU Cochin Broca, Paris
Cabinet Médical, Rambouillet
Clinique Léopold Bellan, Magnanville
Cabinet Médical, Toulon
Cabinet Médical, La Seyne-sur-Mer
Dupuytren Hospital, Limoges
Hôpital Privé Les Magnolias, Ballainvilliers
Cabinet Médical, Rueil-Malmaison
Charles Foix Hospital, Ivry-sur-Seine
Fleyriat Hospital, Bourg-en-Bresse
Cabinet Médical 2, Nice
Cabinet Médical, Nice
Lead Sponsor
Exonhit
INDUSTRY